Atlas Trials

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Clinical trial NCT01657669 · UNKNOWN

Trial details

NCT number
NCT01657669
Sponsor
Retina Research Institute, LLC
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Age Related Macular Degeneration
Start date
2012-10-01
Primary completion
2014-11-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.